Quent Capital, LLC
- SEC CIK
- 0001912338
- Latest filing
- Aug 7, 2026
IBRX holding history
ImmunityBio, Inc. in every 13F filed by Quent Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IBRX overviewAll 13F holders of IBRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 815
- Value
- $7.13K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 815 | $7.13K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 815 | $6.25K | <0.1% | +364+80.7% | Added | Holders |
| Q4 2025 | 451 | $893 | <0.1% | +451 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −1,824−100.0% | Sold out | Holders |
| Q1 2024 | 1,824 | $9.79K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 1,824 | $9.16K | <0.1% | −5−0.3% | Reduced | Holders |
| Q3 2023 | 1,829 | $3.09K | <0.1% | +1,392+318.5% | Added | Holders |
| Q2 2023 | 437 | $1.22K | <0.1% | +35+8.7% | Added | Holders |
| Q1 2023 | 402 | $732 | <0.1% | +89+28.4% | Added | Holders |
| Q4 2022 | 313 | $1.59K | <0.1% | +313 | New | Holders |